Precigen, Inc. (PGEN)

From the record

Precigen, Inc.'s filings since 2017 show 5 warning events of 4 kinds: a notice about its exchange listing (8-K item 3.01, 2 times, the latest 2024-11-07); a warning not to rely on past financial statements (8-K item 4.02, the latest 2018-08-09); an auditor change (8-K item 4.01, the latest 2019-09-16); a late-report notice (Form NT 10-K or NT 10-Q, the latest 2018-08-10) (its current reports).

From the record

Precigen, Inc.'s 10 filed years say what it did: revenue went from $191 million in fiscal 2016 to $10 million in fiscal 2025, down 28.2% a year; it rose in 3 of 9 years; the deepest fall was 98% from fiscal 2017 to fiscal 2024; net income was positive in 1 of 10 of those years (its annual reports).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Precigen, Inc. lost about 1199 cents for every dollar of shareholders' money. Leverage: it owed about 87 cents per dollar of assets, and net share issuance: its share count grew 16.9% over the year (the filed statements).

From the record

Precigen, Inc.'s standing among 315 graded names in its industry family: revenue of $10 million in fiscal 2025 ranks in the bottom 42% by size; a net margin of -2588.2% ranks in the bottom 21%; revenue growth of -28.9% a year over the last 3 filed years ranks in the bottom 18% (its annual reports).

From the record

Precigen, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Sabzevari, Helen (President and CEO, as filed), filing under that title since 2020-01-03, 6.9 years (top 29% of its family); the 13 officers and directors filing in the last fifteen months have been on the record a median of 10.4 years (top 6%); 6 officer or director changes were reported on Form 8-K since 2023-11-13, against the 13 people in charge now (bottom 50%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Precigen, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $30 million against debt of $93 million leaves -40.5% of its assets as net cash, bottom 3% of its family; cash from operations less capital spending is -927.6% of revenue (bottom 27%); research spending of 426.8% of revenue (top 31%) (its annual report).

From the record

Precigen, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew -28.9% a year over the last three filed years against -28.2% over all 10, slowing (top 49% of its family); the newest year grew 146.9% (top 13%); research spending grew -27.8% a year (bottom 14%); capital spending grew -26% a year (bottom 40%) (its annual reports). Precigen, Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

From the record

Precigen, Inc.'s newest year against its own record: revenue of $10 million in fiscal 2025 came in 545.6% above the $2 million its prior three years' pace pointed to (top 7% of its family); net income of $251 million against a prior three-year average of $65 million (bottom 7%); a net margin of a loss larger than its revenue against losses larger than its revenue before (bottom 12%) (its annual reports).